Dostarlimab-gxly
Dostarlimab-gxly
Dostarlimab-gxly (pronunciation: doh-star-LIM-ab GX-ly) is a type of immunotherapy drug used in the treatment of certain types of cancer. It is a monoclonal antibody that works by blocking the activity of a protein called PD-1, thereby boosting the body's immune response against cancer cells.
Etymology
The name "Dostarlimab-gxly" is derived from the International Nonproprietary Names (INN) system. "Dostarlimab" is a combination of "do" (indicating the drug's human origin), "star" (indicating the drug's target, the immune system), "lim" (indicating the drug's role as an immunomodulator), and "ab" (indicating the drug's class as an antibody). The suffix "-gxly" is a unique identifier assigned by the INN.
Usage
Dostarlimab-gxly is used in the treatment of endometrial cancer that has progressed or spread to other parts of the body and is not responsive to other treatments. It is also being studied in the treatment of other types of cancer.
Related Terms
See Also
External links
- Medical encyclopedia article on Dostarlimab-gxly
- Wikipedia's article - Dostarlimab-gxly
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski